Structures by: Sobiak S.
Total: 8
1,2-Dimethyl-4-nitro-5-morpholine-imidazole
C9H14N4O3
Acta Crystallographica Section B (2003) 59, 4 487-491
a=8.589(2)Å b=6.6750(10)Å c=10.657(2)Å
α=90.00° β=112.23(3)° γ=90.00°
1,2-Dimethyl-4-nitro-5-morpholine-imidazole hydrate
C9H14N4O3,H2O
Acta Crystallographica Section B (2003) 59, 4 487-491
a=10.1972(11)Å b=10.2908(9)Å c=11.1812(12)Å
α=95.319(8)° β=92.235(9)° γ=90.777(8)°
1,2-Dimethyl-4-nitro-5-morpholine-imidazole hydrate
C9H14N4O3,H2O
Acta Crystallographica Section B (2003) 59, 4 487-491
a=10.1087(7)Å b=10.2497(8)Å c=10.9623(8)Å
α=95.888(6)° β=92.119(6)° γ=90.188(6)°
2-(5-Bromo-2-methyl-4-nitroimidazol-1-yl)-1-(2-chlorophenyl)ethanone
C12H9BrClN3O3
Acta Crystallographica Section E (2007) 63, 4 o1669-o1671
a=8.4929(8)Å b=23.8609(13)Å c=7.5005(5)Å
α=90.00° β=120.190(7)° γ=90.00°
(<i>E</i>)-1-[4-(Methylsulfanyl)phenyl]-2-(2,3,4-trimethoxyphenyl)ethene
C18H20O3S
Acta Crystallographica Section E (2012) 68, 9 o2791
a=13.9633(4)Å b=7.7094(2)Å c=15.1518(4)Å
α=90.00° β=90.705(3)° γ=90.00°
Monoammonium beta-glycyrrhizate complex with p-aminobenzoic acid 3.53 methanol 1.82 water solvate
C42H61O16,C7H7NO2,3.53(CH4O),H4N,1.82(H2O)
Crystal Growth & Design (2012) 12, 4 2133
a=10.4464(2)Å b=11.2468(2)Å c=51.0762(5)Å
α=90.00° β=90.00° γ=90.00°
Glycyrrhizic acid 4.26 propionic acid 3.94 water solvate
C42H62O16,4.26(C3H6O2),3.94(H2O)
Crystal Growth & Design (2012) 12, 4 2133
a=10.6054(2)Å b=11.3456(2)Å c=52.5014(5)Å
α=90.00° β=90.00° γ=90.00°
Monoammonium beta-glycyrrhizate 3.53 methanol 1.82 water solvate
C42H61O16,6.25(CH4O),H4N,2.04(H2O)
Crystal Growth & Design (2012) 12, 4 2133
a=10.3718(2)Å b=11.2995(2)Å c=50.3536(6)Å
α=90.00° β=90.00° γ=90.00°